Tekni-Plex has opened a new closure liner manufacturing plant in India primarily to serve growing demand for high-quality solutions for regulated pharmaceuticals. The plant is located in Kundli, near Delhi, and will support one of the largest generic drug producing
regions in the world with shorter lead times. It will operate as part of the company’s Tri-Seal liner manufacturing business unit. The liners will be used as a packaging component for a broad range of solid oral dose capsules and tablets.
“With so many multinational and regional pharmaceutical companies located in India, we wanted to improve their speed-to-market by locating a manufacturing plant in close proximity to pharma production. Based on our discussions with customers, we believe that this is the first plant in India laminating liners for regulated applications. This will enable those companies to have a faster supply of liners that have been manufactured to the same regulatory standards required by the US Food and Drug Administration,” said David Andrulon is, senior vice president and general manager, Tekni-Plex.
The plant will include laminating, slitting and punching lines. It also has a capacity to accommodate future expansion requirements as business needs dictate. Tri-Seal manufactures a broad range of liners in a variety of materials ranging from one- and two piece induction heat seals, monolayers, co-extrusions and various laminations.
Packaging South Asia is a cooperating media partner for drupa 2016 which was held from 31 May to 10 June at Dusseldorf, Germany
